Get started
Author

Ivis Perez

Observed institution: Insight Therapeutics
ORCID: 0009-0009-4311-7392
Observed ORCID: 0009-0009-4311-7392
OpenAlex ID: A5122760132
Assessing feasibility of real‑world respiratory virus syndromic surveillance in nursing homes using point‑of‑care molecular testing
2026 · Lisa F. Han, Ivis Perez, et al. · Infection Control and Hospital Epidemiology
PDF
Invasive E. coli Disease in US Nursing Homes: Brief Report of Case Validation Findings
2026 · H. Edward Davidson, Lisa F. Han, et al. · Journal of the American Geriatrics Society
P-2175. A Pilot Study to Establish a Nursing Home Syndromic Surveillance Network
2026 · H Edward Davidson, Lisa Han, et al. · Open Forum Infectious Diseases
P-1599. XBB.1.5 responses present up to a year post COVID-19 mRNA vaccination in long-term care residents with a strong boost from KP.2 vaccination
2026 · David Canaday, Olajide Olagunju, et al. · Open Forum Infectious Diseases
P-647. Symptomatic Presentation and Characteristics of Residents with Test-confirmed Respiratory Infections in a Surveillance Network of US Nursing Homes
2026 · Kevin McConeghy, Lisa Han, et al. · Open Forum Infectious Diseases
P-1481. Does Herpes Zoster ICD Coding with Complications Capture Clinical Severity of Shingles in Nursing Home Residents? A Case Review Study
2026 · Mriganka Singh, Yasin Abul, et al. · Open Forum Infectious Diseases
Respiratory surveillance through point of care molecular testing and its impacts on nursing home RSV, influenza, and SARS-CoV-2 awareness and reporting behavior: a pilot study.
2026 · H. Edward Davidson, Lisa F. Han, et al. · Antimicrobial Stewardship & Healthcare Epidemiology
PDF
Works count: 7
Citation count:
H-index:
I10-index:
Year
Topic
Type